|

LY4152199 - IV Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Eli Lilly and Company1

Indications

  • Lymphoma, B-Cell, Marginal Zone1
  • Lymphoma, Mantle-Cell1
  • Lymphoma, Follicular1
  • Lymphoma, Large B-Cell, Diffuse1
  • Waldenstrom Macroglobulinemia1

Duarte, California1 trial

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

City of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.